#152763

Anti-ELOVL Fatty Acid Elongase 7 [Z26]

Cat. #152763

Anti-ELOVL Fatty Acid Elongase 7 [Z26]

Cat. #: 152763

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: ELOVL Fatty Acid Elongase 7 (ELOVL7)

Class: Monoclonal

Application: ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ELOVL Fatty Acid Elongase 7 [Z26]
  • Alternate name: Elongation of very long chain fatty acids protein 7, 3-keto acyl-CoA synthase ELOVL7, ELOVL fatty acid elongase 7, ELOVL FA elongase, Very long chain 3-ketoacyl-CoA synthase 7, Very long chain 3-oxoacyl-CoA synthase 7
  • Research fields: Cancer;Cell signaling and signal transduction;Metabolism;Tissue-specific biology
  • Clone: Z26
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 35 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: ELOVL Fatty Acid Elongase 7 (ELOVL7) is a condensing enzyme that catalyzes the synthesis of saturated and polyunsaturated very long chain fatty acids. Highest activity toward C18 acyl-CoAs, especially C18:3(n-3) acyl-CoAs. Belongs to the ELO family of proteins which are eukaryotic integral membrane proteins involved in fatty acid elongation. Expressed in most tissues except heart and skeletal muscle. Localised to the endoplasmic reticulum membrane. Biological process keywords: Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism.
  • Immunogen: Peptide Sequence RAYTKGQRLP (peptide immunogen is identical in rat (Rattus norvegicus), mouse (Mus musculus), cow (Bos taurus), dog (Canis familiaris), horse (Equus caballus)
  • Isotype: IgG
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: Jurkat cell lysate

Target Details

  • Target: ELOVL Fatty Acid Elongase 7 (ELOVL7)
  • Molecular weight: 35 kDa
  • Tissue cell line specificity: Jurkat cell lysate
  • Target background: ELOVL Fatty Acid Elongase 7 (ELOVL7) is a condensing enzyme that catalyzes the synthesis of saturated and polyunsaturated very long chain fatty acids. Highest activity toward C18 acyl-CoAs, especially C18:3(n-3) acyl-CoAs. Belongs to the ELO family of proteins which are eukaryotic integral membrane proteins involved in fatty acid elongation. Expressed in most tissues except heart and skeletal muscle. Localised to the endoplasmic reticulum membrane. Biological process keywords: Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism.

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C